Spots Global Cancer Trial Database for diarrhea
Every month we try and update this database with for diarrhea cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy | NCT01438645 | Colonic Neoplas... Iron Deficiency... Diarrhea | Olympus ScopeGu... | 18 Years - | University of Alberta | |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients | NCT04038619 | Colitis Diarrhea Malignant Genit... Melanoma Lung Cancer Ovarian Cancer Uterine Cancer Breast Cancer Cervical Cancer | Fecal Microbiot... Loperamide | 18 Years - | M.D. Anderson Cancer Center | |
| Epidemiological Study of Colorectal Cancer in WuHan | NCT01863303 | Diarrhea Constipation Melena Neoplasm Colonic Neoplas... Pain | 40 Years - 74 Years | Wuhan Pu-Ai Hospital | ||
| Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients | NCT02464098 | Diarrhea | - 18 Years | St. Jude Children's Research Hospital | ||
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | NCT00006269 | Colorectal Canc... Diarrhea | irinotecan hydr... octreotide acet... | 18 Years - | Novartis | |
| A Study of Colesevelam for Lenalidomide-Associated Diarrhea | NCT03767257 | Multiple Myelom... Diarrhea | Colesevelam Pil... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy | NCT00048971 | Colorectal Canc... Diarrhea Neutropenia | mutation analys... polymorphic mic... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer | NCT00036517 | Colorectal Neop... Diarrhea | PHY906 | 18 Years - 75 Years | PhytoCeutica | |
| Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients | NCT01523431 | Metastatic Colo... | Irinotecan Inje... 5-fluorouracil Leucovorin | 18 Years - | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea | NCT01543451 | Diarrhea | Elsiglutide Placebo | 18 Years - | Helsinn Healthcare SA | |
| Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer | NCT06152471 | Early-stage Bre... Diarrhea Adverse Drug Ev... | SPC-flakes Salovum Placebo | 18 Years - | Uppsala University Hospital | |
| N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma | NCT00093353 | Diarrhea Drug/Agent Toxi... Neuroblastoma | cefixime irinotecan hydr... temozolomide | 1 Year - 30 Years | Children's Hospital Los Angeles | |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | NCT01469338 | Diarrhea Hormone-resista... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | cabazitaxel prednisone octreotide pamo... questionnaire a... octreotide acet... | 18 Years - | University of Southern California | |
| L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer Patients | NCT06019312 | Colorectal Canc... Clostridioides ... Diarrhea | Sanprobi IBS® | 18 Years - 65 Years | Medical University of Gdansk | |
| Prospective Randomized Open Label Study of the Treatment of Therapy-associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium - | NCT00444093 | Diarrhea Enteritis Cancer | Opii normata tr... Loperamid Treat... | 18 Years - | Philipps University Marburg Medical Center | |
| The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | NCT01739634 | Diarrhea Medullary Thyro... | CASAD | - | Salient Pharmaceuticals Incorporated | |
| The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | NCT01739634 | Diarrhea Medullary Thyro... | CASAD | - | Salient Pharmaceuticals Incorporated | |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | NCT00033605 | Cervical Cancer Colorectal Canc... Diarrhea Endometrial Can... Fallopian Tube ... Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... Vaginal Cancer Vulvar Cancer | octreotide acet... placebo radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Prevention of Irinotecan Induced Diarrhea by Probiotics | NCT02819960 | Diarrhea Cancer | Probio-Tec® BG-... Placebo | 18 Years - | S&D Pharma SK s.r.o. | |
| A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer | NCT00040391 | Colorectal Neop... Diarrhea | Investigational... Irinotecan 5-fluorouracil Leucovorin | 18 Years - | Celgene Corporation | |
| An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome | NCT00774930 | Carcinoid Syndr... | Lanreotide Placebo | 18 Years - | Ipsen | |
| S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis | NCT03499808 | Amorphous, Eosi... Constipation Diarrhea Early Satiety Gastrointestina... Hepatomegaly Lymphadenopathy Macroglossia Nausea Primary Systemi... Purpura Recurrent Prima... Refractory Prim... | Isatuximab Laboratory Biom... | 18 Years - | SWOG Cancer Research Network | |
| Epidemiological Study of Colorectal Cancer in WuHan | NCT01863303 | Diarrhea Constipation Melena Neoplasm Colonic Neoplas... Pain | 40 Years - 74 Years | Wuhan Pu-Ai Hospital | ||
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | NCT00033605 | Cervical Cancer Colorectal Canc... Diarrhea Endometrial Can... Fallopian Tube ... Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... Vaginal Cancer Vulvar Cancer | octreotide acet... placebo radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer | NCT00084721 | Colorectal Canc... Diarrhea | celecoxib irinotecan hydr... | 18 Years - | Roswell Park Cancer Institute | |
| Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea | NCT01543451 | Diarrhea | Elsiglutide Placebo | 18 Years - | Helsinn Healthcare SA | |
| Prospective Randomized Open Label Study of the Treatment of Therapy-associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium - | NCT00444093 | Diarrhea Enteritis Cancer | Opii normata tr... Loperamid Treat... | 18 Years - | Philipps University Marburg Medical Center | |
| Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. | NCT00258401 | Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma | dietary interve... management of t... quality-of-life... | 20 Years - 80 Years | Case Comprehensive Cancer Center | |
| Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy | NCT01644097 | Diarrhea Unspecified Adu... | Lactobacillus p... Lactobacillus a... placebo laboratory biom... questionnaire a... quality-of-life... Bifidobacterium... | 18 Years - | Stanford University | |
| Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors | NCT04040712 | Diarrhea Caused... Renal Cell Canc... | Donor FMT Sham FMT | 18 Years - | Catholic University of the Sacred Heart | |
| Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. | NCT00258401 | Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma | dietary interve... management of t... quality-of-life... | 20 Years - 80 Years | Case Comprehensive Cancer Center | |
| Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | NCT00006269 | Colorectal Canc... Diarrhea | irinotecan hydr... octreotide acet... | 18 Years - | Novartis | |
| Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer | NCT00003057 | Colorectal Canc... Diarrhea | loperamide hydr... octreotide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study) | NCT04926545 | Malignant Tumor Diarrhea | Xiao Chai Hu Ta... Raloxifene FOLFIRI regimen | 18 Years - 75 Years | Guangzhou University of Traditional Chinese Medicine | |
| Feasibility and Safety of Acupuncture in the Prevention of Late Irinotecan-related Diarrhea in Pediatric Patients | NCT05507736 | Pediatric Cance... Solid Tumor | Acupuncture | 0 Years - 18 Years | Fundació Sant Joan de Déu | |
| FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis | NCT06206707 | Diarrhea Colitis Malignant Melan... Kidney Cancer | Faecal Microbio... Placebo | 18 Years - | University of Aarhus | |
| Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy | NCT00258180 | Diarrhea Gastrointestina... Unspecified Chi... | filgrastim cyclophosphamid... | 1 Year - 21 Years | Johns Hopkins University | |
| Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation | NCT01839721 | Cancer Diarrhea Abdominal Pain Quality of Life | Bifilact® placebo | 18 Years - | CHU de Quebec-Universite Laval | |
| Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation | NCT01371656 | Acute Leukemias... Bacterial Infec... Diarrhea Fungal Infectio... Musculoskeletal... Neutropenia Recurrent Child... Recurrent Child... Secondary Acute... Untreated Child... | levofloxacin | 6 Months - 21 Years | Children's Oncology Group | |
| Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea | NCT00582426 | Chemotherapy-in... | Octreotide Long... Standard Treatm... | 18 Years - 80 Years | Novartis | |
| A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline | NCT02080078 | Non-small Cell ... Advanced Solid ... | Theophylline Erlotinib | 18 Years - | AHS Cancer Control Alberta | |
| CASAD for Severe Diarrhea in the Emergency Department | NCT02018653 | Cancer Diarrhea | Calcium Alumina... Placebo Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure | NCT05091775 | Fissure in Ano Diarrhea | Asacol is used ... | 18 Years - 65 Years | Shiraz University of Medical Sciences | |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | NCT01469338 | Diarrhea Hormone-resista... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | cabazitaxel prednisone octreotide pamo... questionnaire a... octreotide acet... | 18 Years - | University of Southern California | |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | NCT01469338 | Diarrhea Hormone-resista... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | cabazitaxel prednisone octreotide pamo... questionnaire a... octreotide acet... | 18 Years - | University of Southern California | |
| German Colon Capsule Registry | NCT02182466 | Colon Cancer Colon Polyp Diarrhea Inflammatory Bo... Ulcerative Coli... | Colon capsule e... | 18 Years - | Johann Wolfgang Goethe University Hospital | |
| The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | NCT01739634 | Diarrhea Medullary Thyro... | CASAD | - | Salient Pharmaceuticals Incorporated | |
| Feasibility and Safety of Acupuncture in the Prevention of Late Irinotecan-related Diarrhea in Pediatric Patients | NCT05507736 | Pediatric Cance... Solid Tumor | Acupuncture | 0 Years - 18 Years | Fundació Sant Joan de Déu | |
| Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy | NCT01198145 | Diarrhea Gastrointestina... Unspecified Adu... | sulfasalazine placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Effect of the Use of Symbiotics in Patients With Colon Cancer | NCT04874883 | Symbiotic Cancer Colorect... Cancer Head Nec... Intestinal Dysb... Diarrhea Intestinal Micr... Nutritional Sta... | Simbyotic Control Group | 18 Years - | Federal University of Minas Gerais | |
| The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure | NCT05091775 | Fissure in Ano Diarrhea | Asacol is used ... | 18 Years - 65 Years | Shiraz University of Medical Sciences | |
| Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan | NCT00748215 | Chemotherapeuti... Colorectal Canc... Diarrhea | calcium alumino... placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl | NCT04713202 | Neuroendocrine ... Carcinoid Syndr... Diarrhea | Telotristat eth... Peptide Recepto... Placebo | 18 Years - | Big Ten Cancer Research Consortium | |
| Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer | NCT00003057 | Colorectal Canc... Diarrhea | loperamide hydr... octreotide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation | NCT01839721 | Cancer Diarrhea Abdominal Pain Quality of Life | Bifilact® placebo | 18 Years - | CHU de Quebec-Universite Laval |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
